National Treatment Retention Findings from DATOS

19
Slide 1 of 19 National National Treatment Treatment Retention Findings Retention Findings from DATOS from DATOS Charts Prepared & Released for Public Charts Prepared & Released for Public Use by Use by Dwayne Simpson (TCU), Robert Hubbard Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA), & (NDRI-NC), Douglas Anglin (UCLA), & Bennett Fletcher (NIDA) Bennett Fletcher (NIDA) Drug Abuse Treatment Drug Abuse Treatment Outcome Studies Outcome Studies (Funded by NIDA) (Funded by NIDA)

description

Drug Abuse Treatment Outcome Studies (Funded by NIDA). DATOS. National Treatment Retention Findings from DATOS. Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA), & Bennett Fletcher (NIDA). - PowerPoint PPT Presentation

Transcript of National Treatment Retention Findings from DATOS

Page 1: National  Treatment Retention Findings from DATOS

Slide 1 of 19

National National Treatment Treatment

Retention Findings Retention Findings from DATOSfrom DATOS

Charts Prepared & Released for Public Use by Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC),

Douglas Anglin (UCLA), & Bennett Fletcher (NIDA)Douglas Anglin (UCLA), & Bennett Fletcher (NIDA)

Drug Abuse Treatment Drug Abuse Treatment Outcome StudiesOutcome Studies(Funded by NIDA)(Funded by NIDA)

Page 2: National  Treatment Retention Findings from DATOS

Slide 2 of 19

DDrug rug AAbuse buse RReporting eporting PProgramrogramFirst National Evaluation of Treatment Effectiveness

Funded by the Funded by the National National

Institute on Institute on Drug AbuseDrug Abuse

Sells, Simpson, Demaree, & Joe Sells, Simpson, Demaree, & Joe 6 books & 150 papers published (funded 1970-19906 books & 150 papers published (funded 1970-1990))

1969-73

35 Cities

139 Programs

~44,000 Patients

All treatment types

Follow-ups: 1,3,6,12 Yrs

Page 3: National  Treatment Retention Findings from DATOS

Slide 3 of 19

53

64

52

29

53

33

43 42

30

0

20

40

60

80

100

Daily Opioid Use: Daily Opioid Use: % in Year 1 After Discharge% in Year 1 After Discharge

0Days

(IntakeOnly)

1-30Days inDetoxOnly

1-3 3+Mos in

TherapeuticCommunity*

1-3 3+Mos in

OutpatientDrug-Free*

1-3 3-12 12+Mos in

MethadoneMaintenance*

*p<.01

ComparisonGroups Same for criminality !

N=3,248; Simpson & Sells, 1982 (AASA)

Page 4: National  Treatment Retention Findings from DATOS

Slide 4 of 19

TTreatment reatment OOutcome utcome PProspective rospective SStudytudySecond National Evaluation of Treatment Effectiveness

Funded by the Funded by the National National

Institute on Institute on Drug AbuseDrug Abuse

Hubbard, Marsden, Rachal, Harwood, Cavanaugh, & Ginzburg, Hubbard, Marsden, Rachal, Harwood, Cavanaugh, & Ginzburg, Drug abuse treatment: A national study of effectivenessDrug abuse treatment: A national study of effectiveness (1989) (1989)

1979-81

10 Cities

37 Programs

~11,000 Patients

All treatment types

Follow-up: 1 year

Page 5: National  Treatment Retention Findings from DATOS

Slide 5 of 19

““Treatment Process” in Treatment Process” in TOPSTOPS

Comparisons between 21 MM programs

Programs with Longer Retention had -Better assessment & program planning

Higher MM dose & better UA monitoring

Comprehensive (“wrap-around”) services

Higher patient ratings for “meeting needs”

Similar findings for other modalitiesSimilar findings for other modalities

Joe, Simpson, & Hubbard, 1991 (J Sub Abuse)

Page 6: National  Treatment Retention Findings from DATOS

Slide 6 of 19

DDrug rug AAbuse buse TTreatment reatment OOutcome utcome SStudiestudiesThird National Evaluation of Treatment Effectiveness

Over Over 40 Studies Published40 Studies Published – – Psychology of Addictive BehaviorsPsychology of Addictive Behaviors (Dec 97) (Dec 97)Drug and Alcohol DependenceDrug and Alcohol Dependence (Dec 99) (Dec 99) Archives of General PsychiatryArchives of General Psychiatry (June 99) (June 99)

Funded by the Funded by the National National

Institute on Institute on Drug AbuseDrug Abuse

1991-93

11 Cities

96 Programs

~10,000 Patients

All treatment types

Follow-up: 1 & 5 Yrs

Page 7: National  Treatment Retention Findings from DATOS

Slide 7 of 19

Long-Term ResidentialLong-Term Residential (LTR)Treatment(LTR)Treatment

Changes from Before to After TreatmentChanges from Before to After Treatment

66

2217

6

40

19

41

16

88

77

24

13

0

20

40

60

80

100

Cocaine (Weekly)*

Heroin (Weekly)*

Heavy Alcohol*

Illegal Activity*

No FTWork*

SuicidalIdeation*

Pre Post

% of DATOS Sample (N=676)*p<.001

Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997 (PAB)

Page 8: National  Treatment Retention Findings from DATOS

Slide 8 of 19

Outpatient Drug-FreeOutpatient Drug-Free (ODF) (ODF) TreatmentTreatment

Changes from Before to After TreatmentChanges from Before to After Treatment

42

1825

9

31

1522

14

8276

19

11

0

20

40

60

80

100

Cocaine (Weekly)*

Marijuana (Weekly)*

Heavy Alcohol*

Illegal Activity*

No FTWork*

SuicidalIdeation*

Pre Post

% of DATOS Sample (N=764)*p<.001

Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997 (PAB)

Page 9: National  Treatment Retention Findings from DATOS

Slide 9 of 19

42

22

89

28

15 16

29

14

85 82

1713

0

20

40

60

80

100

Cocaine (Weekly)*

Heroin (Weekly)*

Heavy Alcohol

Illegal Activity*

No FTWork

SuicidalIdeation

Pre Post

% of DATOS Sample (N=727)

Outpatient Methadone TreatmentOutpatient Methadone Treatment (OMT)(OMT)

Changes from Before to After TreatmentChanges from Before to After Treatment

*p<.001

Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997 (PAB)

Page 10: National  Treatment Retention Findings from DATOS

Slide 10 of 19

Average Average ExpectedExpected vs vs ObservedObserved Length of Stay by Patients Length of Stay by Patients (in (in

months)months)

96

24

3 3

12

Long-TermResidential

(n=17)

Outpatient Drug-Free

(n=14)

OutpatientMethadone

(n=10)

Observed (Median)Expected (Median)

Simpson, Joe, Broome, Hiller, Knight, Rowan-Szal, 1997 (PAB)

Page 11: National  Treatment Retention Findings from DATOS

Slide 11 of 19

Patient Retention Rates for Patient Retention Rates for ProgramsPrograms

(beyond minimum “thresholds”)(beyond minimum “thresholds”)

65%75% 76%

21% 16% 15%

3+ Mos inLong-TermResidential

(n=17)

3+ Mos in Outpatient Drug-Free

(n=14)

12+ Mos inOutpatient

Methadone (n=10)

BestProgram

PoorestProgram

Simpson, Joe, Broome, Hiller, Knight, Rowan-Szal, 1997 (PAB)

Page 12: National  Treatment Retention Findings from DATOS

Slide 12 of 19

Program Retention Rates in Program Retention Rates in LTRLTR(for 90 days or longer)(for 90 days or longer)

21

3133

4043 43 43 44

50 50 50

56 56 5759

6165

% of Admissions to 17 LTR Programs (with 40+ patients)

Page 13: National  Treatment Retention Findings from DATOS

Slide 13 of 19

Program Retention Rates in Program Retention Rates in ODFODF(for 90 days or longer)(for 90 days or longer)

1619

31

40 4144

51

56 57 5861

6769

75

% of Admissions to 14 ODF Programs (with 40+ patients)

Page 14: National  Treatment Retention Findings from DATOS

Slide 14 of 19

Program Retention Rates in Program Retention Rates in OMTOMT(for 360 days or longer)(for 360 days or longer)

1520

4246 47 49

5255

63

76

% of Admissions to 10 OMT Programs (with 40+ patients)

Page 15: National  Treatment Retention Findings from DATOS

Slide 15 of 19

Example from LTR in DATOSExample from LTR in DATOSExample from LTR in DATOSExample from LTR in DATOS

Retention Predicts Retention Predicts OutcomesOutcomes

Findings Consistent from National Studies1970s (44,000 admissions in DARP)

1980s (11,000 admissions in TOPS)

1990s (10,000 admissions in DATOS)

Also in England’s NTORS !

Conclusions from Major ReviewsInstitute of Medicine (Gerstein & Harwood, ‘90)

Page 16: National  Treatment Retention Findings from DATOS

Slide 16 of 19

Comparison of Year 1 Comparison of Year 1 Outcomes Outcomes

by Length of Stay in by Length of Stay in LTRLTR

55

28

53

1915

9

54

24

0

20

40

60

80

100

Cocaine (Any Use)*

UA+ (Any Drug)*

Alcohol (Daily Use)*

Any Jail*

< 90 Days 90+ Days

% of Sample

*p<.001

N=342; Simpson, Joe, & Brown, 1997 (PAB)

Page 17: National  Treatment Retention Findings from DATOS

Slide 17 of 19

DATOS Programs with DATOS Programs with Lower Lower RetentionRetention had more “troubled” had more “troubled”

caseloads!caseloads!

Admissions to these programs had -

More cocaine & alcohol problems More previous treatments More psychological problems

But these patient problems did not explainall program differences in retention rates!

Simpson, Joe, Broome, Hiller, Knight, Rowan-Szal, 1997 (PAB)

Page 18: National  Treatment Retention Findings from DATOS

Slide 18 of 19

Patient Problems in Patient Problems in LTRLTR Programs Programs

6782

9686 86

75

41

6

42 33 4429

Highest %

Lowest %

Page 19: National  Treatment Retention Findings from DATOS

Slide 19 of 19

Selected Studies

1-Year Outcomes

Treatment Services

& Process

CocaineTreatment

SelectedWeb Posters

AdolescentStudies

Cost Benefits ofMM Treatment

Readinessfor Treatment

News and FeaturesHome Page

About DATOS

Background

Highlights

Special Topics

Publications

Web Posters

What’s New

CONTENT

Cocaine Treatment Outcome Study is Released(in June 1999 issue of Archives of General Psychiatry)Findings emphasize the need for "adequate treatment stays," especially when problem severity is moderate-to-high.  At least 90 days in intensive residential (TC) programs was indicated for high-severity cases. More information is provided in a new section of Highlights page, "Outcomes for Treatment of Cocaine Dependence.”

 

Latest DATOS studies have been published in Drug and Alcohol DependenceTreatment process (engagement and participation), retention, and outcomes are the focus of this series of studies, and our first cost-benefit analysis addresses cocaine treatment.  The latest DATOS publications and "in press" are listed on the Publications page.

 

www.datos.orgwww.datos.org